Mad Money: What Works for 2008 - Mad Cap Recap

FEATURED SLIDESHOW

  Who Is The Worst CEO?
Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
  nominations.

RECENT POSTS

Get stock and market information from Mad Money's Jim Cramer sent to your mobile phone.

Road Rules

Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

Watch the Videos

Text Size

Jan.03

9:29 AM ET

Thursday, 3 Jan 2008

What Works for 2008

Posted By:Tom Brennan

Topics:Stock Picks | Stock Market

Cramer spent Wednesday’s show reviewing what went right and wrong in 2007 for his nine stocks of the year. Here’s the breakdown on what he said is in store for his picks in 2008:

The Federal Reserve should finally take rates low enough to turn around the financials. When that happens, Goldman Sachs [GS Loading... () ] should earn $30 a share, boosting the share price to $300.

Altria’s split of its international and domestic businesses and “the mother of all buybacks” should send the stock much higher, Cramer said.

Halliburton [HAL Loading... () ] should would since Cramer said he thinks 2008 is the year for natural gas. But he has a player in that sector he likes better, so tune in Thursday to find out who it is.

Cisco [CSCO Loading... () ] will just be a “marginal performer” going forward. If you want tech, go with Apple [AAPL Loading... () ], Google [GOOG Loading... () ], Research in Motion [RIMM Loading... () ] and Hewlett-Packard [HPQ Loading... () ].

Even though Apple’s coming off a great year, Cramer said 2008 could be good as well. He recommended sticking with AAPL.

NYSE Euronext [NYX Loading... () ], the bane of 2007 for Cramer, should turn around this year, he said. Cost cuts by new CEO Duncan Niderauer should do wonders for the bottom line.

BioMarin [BMRN Loading... () ] has the only Food and Drug Administration-approved remedy for Phenylketonuria and a pipeline that has Cramer impressed. It’s a keeper, he said.

Cramer can’t recommend Rite-Aid [RAD Loading... () ] until the drug-store chain offers up a solid quarter, but with CEO Jim Crow returning to Level 3 [LVLT Loading... () ], he’s sticking with the company, especially because of the growth in web video.

CLICK FOR THE REST OF WEDNESDAY'S SHOW:

Jim's charitable trust owns Goldman Sachs, Hewlett-Packard and NYSE Euronext.

Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?

Tools:

Print Email

Previous Post Back to Main Page

ADD COMMENTS